← Open Payments lookup

DAVID ATKINS: Open Payments

NPI 1003142852 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$686 in 29 payments from 15 companies in 2025. Trend: 2023 $563 · 2024 $126 · 2025 $686

Food & beverage: $686
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP3$201
Lilly USA, LLC8$158
Gilead Sciences, Inc.4$80
Novo Nordisk Inc2$36
Collegium Pharmaceutical, Inc.2$34
Verona Pharma, Inc.1$23
Merck Sharp & Dohme LLC1$22
Alnylam Pharmaceuticals Inc.1$21
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$21
SANOFI-AVENTIS U.S. LLC1$17

Products named: MOUNJARO, FARXIGA, AIRSUPRA, Wegovy, Jornay PM, Ohtuvayre, LAGEVRIO, GIVLAARI.

Industry payments across KY — which companies pay providers there.